Nova Eye (Australia) Buy Hold or Sell Recommendation
| EYE Stock | 0.15 0.01 6.25% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Nova Eye Medical is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Nova Eye Medical given historical horizon and risk tolerance towards Nova Eye. When Macroaxis issues a 'buy' or 'sell' recommendation for Nova Eye Medical, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Nova Eye Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Nova and provide practical buy, sell, or hold advice based on investors' constraints. Nova Eye Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Nova |
Execute Nova Eye Buy or Sell Advice
The Nova recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nova Eye Medical. Macroaxis does not own or have any residual interests in Nova Eye Medical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nova Eye's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Nova Eye Trading Alerts and Improvement Suggestions
| Nova Eye Medical generated a negative expected return over the last 90 days | |
| Nova Eye Medical has some characteristics of a very speculative penny stock | |
| Nova Eye Medical has high historical volatility and very poor performance | |
| The company reported the revenue of 23.32 M. Net Loss for the year was (8.79 M) with profit before overhead, payroll, taxes, and interest of 14.39 M. | |
| Nova Eye Medical has accumulated about 7.42 M in cash with (7.73 M) of positive cash flow from operations. | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Nova Eye Medical Discusses Future Expectations and Risks - TipRanks |
Nova Eye Returns Distribution Density
The distribution of Nova Eye's historical returns is an attempt to chart the uncertainty of Nova Eye's future price movements. The chart of the probability distribution of Nova Eye daily returns describes the distribution of returns around its average expected value. We use Nova Eye Medical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nova Eye returns is essential to provide solid investment advice for Nova Eye.
| Mean Return | -0.44 | Value At Risk | -6.67 | Potential Upside | 6.67 | Standard Deviation | 4.67 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nova Eye historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Nova Eye Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation | 1.4M | 1.5M | 1.8M | 2.3M | 3.0M | 3.1M | |
| Other Non Cash Items | (3.9M) | (8.7M) | 521K | 10.4M | 37K | 35.2K | |
| Capital Expenditures | 1.7M | 2.2M | 5.6M | 800K | 449K | 426.6K | |
| End Period Cash Flow | 95.6M | 17.8M | 8M | 7.4M | 6.2M | 6.7M | |
| Change In Cash | 80.3M | (77.8M) | (9.8M) | (581K) | (1.3M) | (1.2M) | |
| Free Cash Flow | 3.8M | (15.4M) | (10.3M) | (7.5M) | (8.3M) | (7.9M) | |
| Net Income | (10.3M) | (4.4M) | (7.5M) | (15.3M) | (8.8M) | (8.4M) | |
| Change To Inventory | 3.8M | 33K | (639K) | (266K) | (477K) | (500.9K) | |
| Net Borrowings | (13.3M) | (582K) | (402K) | (653K) | (587.7K) | (617.1K) | |
| Change To Netincome | (50.8M) | (665K) | (1.4M) | 6.0M | 5.4M | 5.7M |
Nova Eye Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nova Eye or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nova Eye's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nova stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.46 | |
β | Beta against Dow Jones | 0.1 | |
σ | Overall volatility | 4.72 | |
Ir | Information ratio | -0.12 |
Nova Eye Volatility Alert
Nova Eye Medical exhibits very low volatility with skewness of 0.26 and kurtosis of 0.52. Nova Eye Medical is a potential penny stock. Although Nova Eye may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Nova Eye Medical. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Nova instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Nova Eye Fundamentals Vs Peers
Comparing Nova Eye's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nova Eye's direct or indirect competition across all of the common fundamentals between Nova Eye and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nova Eye or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nova Eye's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nova Eye by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nova Eye to competition |
| Fundamentals | Nova Eye | Peer Average |
| Return On Equity | -0.39 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Profit Margin | (0.38) % | (1.27) % |
| Operating Margin | (0.26) % | (5.51) % |
| Current Valuation | 32.7 M | 16.62 B |
| Shares Outstanding | 229.06 M | 571.82 M |
| Shares Owned By Insiders | 18.59 % | 10.09 % |
| Shares Owned By Institutions | 18.74 % | 39.21 % |
| Price To Book | 1.66 X | 9.51 X |
| Price To Sales | 1.47 X | 11.42 X |
| Revenue | 23.32 M | 9.43 B |
| Gross Profit | 14.39 M | 27.38 B |
| EBITDA | (5.98 M) | 3.9 B |
| Net Income | (8.79 M) | 570.98 M |
| Cash And Equivalents | 7.42 M | 2.7 B |
| Total Debt | 3.35 M | 5.32 B |
| Book Value Per Share | 0.09 X | 1.93 K |
| Cash Flow From Operations | (7.73 M) | 971.22 M |
| Earnings Per Share | (0.04) X | 3.12 X |
| Target Price | 0.59 | |
| Beta | 0.96 | -0.15 |
| Market Capitalization | 34.36 M | 19.03 B |
| Total Asset | 29.88 M | 29.47 B |
| Retained Earnings | (30.69 M) | 9.33 B |
| Working Capital | 9.07 M | 1.48 B |
| Net Asset | 29.88 M |
Nova Eye Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nova . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Nova Eye Buy or Sell Advice
When is the right time to buy or sell Nova Eye Medical? Buying financial instruments such as Nova Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nova Eye in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Raw Materials Thematic Idea Now
Raw Materials
Companies that are involved with the development and processing of raw materials such as silver or forestry. The Raw Materials theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Raw Materials Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Nova Stock Analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.